Kay Stubenrauch

Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies

Wolfgang Schaefer, Jörg T. Regula, Monika Bähner et al. · Proceedings of the National Academy of Sciences · 2011 · 457 citations · Full text

Immunocytochemical Technique, Immunology, Immunodominance +26

Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival

Jonas Kloepper, Lars Riedemann, Zohreh Amoozgar et al. · Proceedings of the National Academy of Sciences · 2016 · 350 citations · Full text

Targeting key angiogenic pathways with a bispecific Cross <scp>MA</scp> b optimized for neovascular eye diseases

Jörg T. Regula, Peter Lundh von Leithner, Richard Foxton et al. · EMBO Molecular Medicine · 2016 · 333 citations · Full text

Low immunogenicity of tocilizumab in patients with rheumatoid arthritis

Gerd R Burmester, Ernest Choy, Alan Kivitz et al. · Annals of the Rheumatic Diseases · 2016 · 101 citations · Full text

First-in-Human Phase I Study of Single-agent Vanucizumab, A First-in-Class Bispecific Anti-Angiopoietin-2/Anti-VEGF-A Antibody, in Adult Patients with Advanced Solid Tumors

Manuel Hidalgo, Maria Martinez‐García, Christophe Le Tourneau et al. · Clinical Cancer Research · 2017 · 99 citations